Capital Fund Management S.A. Uni Qure N.V. Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$35.35 - $50.67 $512,539 - $734,664	-14,499 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $971 - $1,286	27 Added 0.19%	14,499 $533,000
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $377,242 - $567,119	8,372 Added 137.25%	14,472 $652,000
Q1 2020 May 13, 2020	BUY	$40.01 - $73.97 $88,942 - $164,435	2,223 Added 57.34%	6,100 $289,000
Q4 2019 Feb 13, 2020	BUY	$37.13 - $74.62 $143,953 - $289,301	3,877 New	3,877 $278,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.